Showing results (91-100 of 197) with videos related to
Sort By:
Pageof 20
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 3, 2021
DNA Methylation as a Diagnostic Biomarker for Malignant Mesothelioma: A Systematic Review and Meta-AnalysisJanah Vandenhoeck, Jan P van Meerbeeck, Erik Fransen, et al.Lung Cancer (Amsterdam, Netherlands)|June 5, 2017
Recurrent dysphasia due to nivolumab-induced encephalopathy with presence of Hu autoantibodyJo Raskin, Pegah Masrori, Antonin Cant, et al.Expert Opinion on Investigational Drugs|June 25, 2013
BIBF 1120/ nintedanib : a new triple angiokinase inhibitor-directed therapy in patients with non-small cell lung cancerChristian Rolfo, Luis E Raez, Giuseppe Bronte, et al.Insights Into Imaging|November 17, 2017
Evaluation of the solitary pulmonary nodule: size matters, but do not ignore the power of morphologyAnnemie Snoeckx, Pieter Reyntiens, Damien Desbuquoit, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesotheliomaAndrew Bottomley, Corneel Coens, Fabio Efficace, et al.Cancers|August 12, 2023
Health Outcomes with Curative and Palliative Therapies in Real World: Role of the Quality of Life Summary Score in Thoracic Oncology PatientsKurt G Tournoy, Valerie Adam, Inge Muylle, et al.International Journal of Radiation Oncology, Biology, Physics|March 31, 2004
Hypofractionated external beam radiotherapy as retreatment for symptomatic non-small-cell lung carcinoma: an effective treatment?Gijsbert W P M Kramer, Steven Gans, Eric Ullmann, et al.Lung Cancer (Amsterdam, Netherlands)|December 31, 2003
Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesotheliomaRob J van Klaveren, Joachim G J V Aerts, Hein de Bruin, et al.Insights Into Imaging|April 13, 2018
Imaging of urgencies and emergencies in the lung cancer patientBruno De Potter, Jef Huyskens, Birgitta Hiddinga, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2005
Phase III trial of gemcitabine plus carboplatin versus single-agent gemcitabine in the treatment of locally advanced or metastatic non-small-cell lung cancer: the Swedish Lung Cancer Study GroupChrister Sederholm, Gunnar Hillerdal, Kristina Lamberg, et al.Pageof 20